Literature DB >> 20598833

Perceived drug assignment and treatment outcome in smokers given nicotine patch therapy.

Steffani R Bailey1, Dalea M Fong, Susan W Bryson, Stephen P Fortmann, Joel D Killen.   

Abstract

This study assessed the relationship between treatment outcome and perceived drug assignment in smokers (nicotine patch [NP] or placebo) using abstinence and relapse status. Smokers (N = 424) were randomly assigned to receive either NP or placebo as part of a study that examined the effects of combining NP with self-help programs. Beliefs about drug assignment, assessed at the 12-month follow-up, were obtained from 384 participants. Beliefs were related to abstinence at the 2-month, p < .05, and 6-month follow-ups, p < .05, for the NP group, but not the placebo. Beliefs were not related to abstinence at 12 months for either group. Survival analysis assessing relapse revealed that beliefs were related to relapse status, regardless of actual group assignment. Our results suggest that there is a relationship between perceived drug assignment and treatment outcome. Future studies using multiple treatment outcome measures and assessments of beliefs over time are warranted. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20598833      PMCID: PMC2910821          DOI: 10.1016/j.jsat.2010.05.013

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  17 in total

Review 1.  Validity of clinical trials of antidepressants.

Authors:  F M Quitkin; J G Rabkin; J Gerald; J M Davis; D F Klein
Journal:  Am J Psychiatry       Date:  2000-03       Impact factor: 18.112

Review 2.  The blind spot in the nicotine replacement therapy literature: assessment of the double-blind in clinical trials.

Authors:  Marc Mooney; Thom White; Dorothy Hatsukami
Journal:  Addict Behav       Date:  2004-06       Impact factor: 3.913

3.  Classification and assessment of smoking behavior.

Authors:  D J Ossip-Klein; G Bigelow; S R Parker; S Curry; S Hall; S Kirkland
Journal:  Health Psychol       Date:  1986       Impact factor: 4.267

4.  How blind is blind? Assessment of patient and doctor medication guesses in a placebo-controlled trial of imipramine and phenelzine.

Authors:  J G Rabkin; J S Markowitz; J Stewart; P McGrath; W Harrison; F M Quitkin; D F Klein
Journal:  Psychiatry Res       Date:  1986-09       Impact factor: 3.222

5.  Belief about drug assignment and abstinence in treatment of cigarette smoking using nortriptyline.

Authors:  Sharon M Hall; Julie A Gorecki; Victor I Reus; Gary L Humfleet; Ricardo F Muñoz
Journal:  Nicotine Tob Res       Date:  2007-04       Impact factor: 4.244

Review 6.  Placebo effects of tobacco smoking and other nicotine intake.

Authors:  Kenneth Perkins; Michael Sayette; Cynthia Conklin; Anthony Caggiula
Journal:  Nicotine Tob Res       Date:  2003-10       Impact factor: 4.244

Review 7.  Placebo interventions for all clinical conditions.

Authors:  A Hróbjartsson; P C Gøtzsche
Journal:  Cochrane Database Syst Rev       Date:  2004

8.  Measures of abstinence in clinical trials: issues and recommendations.

Authors:  John R Hughes; Josue P Keely; Ray S Niaura; Deborah J Ossip-Klein; Robyn L Richmond; Gary E Swan
Journal:  Nicotine Tob Res       Date:  2003-02       Impact factor: 4.244

9.  Blindness and the validity of the double-blind procedure.

Authors:  J R Hughes; D Krahn
Journal:  J Clin Psychopharmacol       Date:  1985-06       Impact factor: 3.153

10.  Can the blind see? Participant guess about treatment arm assignment may influence outcome in a clinical trial of bupropion for smoking cessation.

Authors:  Robert A Schnoll; Leonard Epstein; Janet Audrain; Raymond Niaura; Larry Hawk; Peter G Shields; Caryn Lerman; E Paul Wileyto
Journal:  J Subst Abuse Treat       Date:  2007-06-27
View more
  3 in total

1.  Perceived medication assignment during a placebo-controlled laboratory study of varenicline: temporal associations of treatment expectancies with smoking-related outcomes.

Authors:  John B Correa; Bryan W Heckman; Nicole S Marquinez; David J Drobes; Marina Unrod; Richard G Roetzheim; Thomas H Brandon
Journal:  Psychopharmacology (Berl)       Date:  2014-01-10       Impact factor: 4.530

2.  Prescribing cannabis for harm reduction.

Authors:  Mark Collen
Journal:  Harm Reduct J       Date:  2012-01-01

Review 3.  Nicotine replacement therapy versus control for smoking cessation.

Authors:  Jamie Hartmann-Boyce; Samantha C Chepkin; Weiyu Ye; Chris Bullen; Tim Lancaster
Journal:  Cochrane Database Syst Rev       Date:  2018-05-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.